linewasher51
About
First-line pembrolizumab compared to chemotherapy in metastatic non-small-cell carcinoma of the lung: KEYNOTE-024 Asia subset.
First-line pembrolizumab compared to chemotherapy in metastatic non-small-cell carcinoma of the lung: KEYNOTE-024 Asia subset.